BM-MSCs may also regulate blood glucose levels, reduce demyelination and the production of ROS, and enhance the expression of nerve growth factor (NGF) and VEGF in STZ-induced DN in rats. The gene discussed is NGF; the disease is liver dysplastic nodule.